Pt Kalbe Farma TbkIDX: KLBF

Company Update - Q2 2025 Unaudited Results (07-August-2025)

· Issued by PT Kalbe Farma Tbk

Aug 2025

PT Kalbe Farma Tbk (KLBF IJ/KLBF.JK)

Company Presentation

1 1

YTD Jun 2025





Table of Contents
  • Key Updates 04
  • Business Strategies 09
  • Financial Overview 24
  • Appendix 1 31
  • Appendix 2 38

3

Key Updates

4





Key updates

Business Strategy

Financial Updates

Appendix I

Appendix II

‌More than Half a Century of Providing Wide-Range Healthcare Solutions

Corporate Overview

Net Sales

IDR 17.1 tn



7%

Export

93%

Domestic

33.3%

Distribution &

Logistics

23.4%

Nutritionals

28.9%

Prescription Pharmaceuticals

14.4%

Consumer Health

Market Capitalization*

IDR 71.4 tn | USD 4.4 bn

*As of 30 June '25

Free Float*

38.4%

Treasury Shares*

3.03%

Establishment

1966

IDX Listed

1991

Free Float is calculated as total shares deducted by the majority, affiliated boards, and treasury shares 5

Attention: This is an excerpt of the original content. To continue reading it, access the original document here.